000 01769nam  2200385zi 4500
0019.882031
003CaOODSP
00520221107170206
006m     o  d f      
007cr cn|||||||||
008191115t20202019onca    o    f000 0 eng d
020 |a9780660332635
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
045 |ay1y1
0861 |aHP40-265/1-2019E-PDF
24500|aAntimicrobial resistance and antimicrobial use in Canada : |bcommunity sector.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2020.
264 4|c©2019
300 |a1 online resource (1 page) : |bcolour illustrations
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Résistance aux antimicrobiens et utilisation d'antimicrobiens au Canada : comunauté.
500 |a"CARSS Canadian antimicrobial resistance surveillance system."
500 |a"January 2, 2020."
500 |a"Pub.: 190456."
500 |aIssued also in HTML format.
650 0|aDrug resistance in microorganisms|zCanada.
650 0|aAnti-infective agents|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tRésistance aux antimicrobiens et utilisation d'antimicrobiens au Canada : |w(CaOODSP)9.882033
85640|qPDF|s639 KB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP40-265-1-2019-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2020-46/issue-1-january-2-2020/article-1c-antimicrobial-resistance-community-settings.html